Stratos Wealth Partners LTD. Has $1.11 Million Stake in SPDR S&P Biotech (XBI)

Stratos Wealth Partners LTD. grew its position in SPDR S&P Biotech (NYSEARCA:XBI) by 11.0% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,794 shares of the exchange traded fund’s stock after purchasing an additional 1,266 shares during the period. Stratos Wealth Partners LTD.’s holdings in SPDR S&P Biotech were worth $1,108,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. Ballentine Partners LLC purchased a new stake in shares of SPDR S&P Biotech in the second quarter valued at about $121,000. National Planning Corp purchased a new stake in shares of SPDR S&P Biotech in the second quarter valued at about $211,000. Boston Advisors LLC purchased a new stake in shares of SPDR S&P Biotech in the second quarter valued at about $213,000. Bingham Osborn & Scarborough LLC purchased a new stake in shares of SPDR S&P Biotech in the third quarter valued at about $216,000. Finally, Northstar Asset Management LLC purchased a new stake in shares of SPDR S&P Biotech in the third quarter valued at about $217,000.

COPYRIGHT VIOLATION WARNING: “Stratos Wealth Partners LTD. Has $1.11 Million Stake in SPDR S&P Biotech (XBI)” was first published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are reading this report on another domain, it was copied illegally and reposted in violation of US and international copyright laws. The correct version of this report can be accessed at https://www.chaffeybreeze.com/2017/11/17/stratos-wealth-partners-ltd-has-1-11-million-stake-in-spdr-sp-biotech-xbi.html.

SPDR S&P Biotech (XBI) traded up $1.38 on Friday, reaching $81.43. 3,854,700 shares of the company traded hands, compared to its average volume of 4,235,956. SPDR S&P Biotech has a one year low of $58.66 and a one year high of $88.98.

SPDR S&P Biotech Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.

Institutional Ownership by Quarter for SPDR S&P Biotech (NYSEARCA:XBI)

Receive News & Ratings for SPDR S&P Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply